Go Pro

Ryerson (RYZ) Financials

Ryerson logo
$28.83 -0.03 (-0.10%)
As of 12:03 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for Ryerson

Annual Income Statements for Ryerson

This table shows Ryerson's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-0.50 19 17 106 82 -66 294 391 146 -8.60 -56
Consolidated Net Income / (Loss)
-1.80 19 18 106 83 -65 295 392 146 -7.30 -55
Net Income / (Loss) Continuing Operations
-1.80 19 18 37 83 -65 295 392 146 -7.30 -55
Total Pre-Tax Income
1.90 26 17 117 115 -90 389 523 194 -7.40 -71
Total Operating Income
109 122 101 139 211 65 545 579 228 32 -31
Total Gross Profit
568 571 583 758 828 621 1,147 1,310 1,022 834 782
Total Revenue
3,167 2,860 3,365 4,408 4,502 3,467 5,675 6,324 5,109 4,599 4,571
Operating Revenue
3,167 2,860 3,365 4,408 4,502 3,467 5,675 6,324 5,109 4,599 4,571
Total Cost of Revenue
2,600 2,289 2,782 3,650 3,674 2,846 4,529 5,014 4,087 3,765 3,789
Operating Cost of Revenue
2,600 2,289 2,782 3,650 3,674 2,846 4,529 5,014 4,087 3,765 3,789
Total Operating Expenses
459 449 481 619 617 557 602 731 794 803 813
Selling, General & Admin Expense
451 448 481 615 637 554 711 735 794 801 810
Impairment Charge
7.70 - - - - - - - 0.00 0.00 3.40
Restructuring Charge
2.50 1.00 0.00 4.20 2.40 2.20 - 0.00 0.00 3.10 0.00
Other Special Charges / (Income)
-1.90 - 0.00 0.00 -22 0.00 -110 -3.80 0.00 -1.60 0.00
Total Other Income / (Expense), net
-107 -96 -84 -92 -96 -155 -156 -56 -34 -39 -40
Interest Expense
96 90 91 99 93 76 155 55 35 43 39
Other Income / (Expense), net
-10 -6.10 6.60 6.90 -2.40 -78 -0.90 -1.30 0.30 4.10 -1.50
Income Tax Expense
3.70 7.20 -1.30 10 33 -25 94 131 47 -0.10 -16
Net Income / (Loss) Attributable to Noncontrolling Interest
-1.30 0.20 0.90 0.40 0.30 0.50 1.10 0.50 0.70 1.30 1.30
Basic Earnings per Share
($0.02) $0.55 $0.46 $2.84 $2.19 ($1.73) $7.67 $10.41 $4.17 ($0.26) ($1.76)
Weighted Average Basic Shares Outstanding
25M 34.30M 37.18M 37.30M 37.60M 38.12M 38.39M 36.99M 34.02M 31.85M 51.48M
Diluted Earnings per Share
($0.02) $0.54 $0.46 $2.81 $2.17 ($1.73) $7.56 $10.21 $4.10 ($0.26) ($1.76)
Weighted Average Diluted Shares Outstanding
25M 34.30M 37.18M 37.30M 37.60M 38.12M 38.39M 36.99M 34.02M 31.85M 51.48M
Weighted Average Basic & Diluted Shares Outstanding
25M 34.30M 37.18M 37.30M 37.60M 38.12M 38.39M 36.99M 34.02M 31.85M 51.48M
Cash Dividends to Common per Share
- - - - $0.00 $0.00 $0.17 $0.54 $0.72 $0.75 $0.75

Quarterly Income Statements for Ryerson

This table shows Ryerson's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders
26 -7.60 9.90 -6.60 -4.30 -5.60 1.90 -15 -38 4.50 16
Consolidated Net Income / (Loss)
26 -7.40 10 -6.00 -4.20 -5.30 2.10 -14 -38 5.00 16
Net Income / (Loss) Continuing Operations
26 -7.40 10 -6.00 -4.20 -5.30 2.10 -14 -38 5.00 16
Total Pre-Tax Income
34 -9.50 13 -6.40 -4.80 -6.90 -6.30 -10 -48 13 22
Total Operating Income
44 0.80 23 5.30 2.60 2.30 5.80 -1.00 -38 23 34
Total Gross Profit
247 218 224 202 191 204 209 200 169 289 355
Total Revenue
1,112 1,239 1,226 1,127 1,007 1,136 1,169 1,162 1,105 1,567 2,006
Operating Revenue
1,112 1,239 1,226 1,127 1,007 1,136 1,169 1,162 1,105 1,567 2,006
Total Cost of Revenue
865 1,022 1,002 925 816 931 960 962 936 1,278 1,651
Operating Cost of Revenue
865 1,022 1,002 925 816 931 960 962 936 1,278 1,651
Total Operating Expenses
204 217 201 197 189 202 204 201 207 266 321
Selling, General & Admin Expense
204 217 199 197 189 202 202 201 203 265 320
Impairment Charge
- - - - - 0.00 1.80 - - 0.40 0.50
Total Other Income / (Expense), net
-10 -10 -9.50 -12 -7.40 -9.20 -12 -9.30 -9.80 -10 -12
Interest Expense
9.50 10 11 12 10 9.50 9.80 10 9.50 12 14
Other Income / (Expense), net
-0.50 -0.20 1.80 -0.20 2.70 0.30 -2.30 0.80 -0.30 1.70 1.90
Income Tax Expense
7.50 -2.10 3.00 -0.40 -0.60 -1.60 -8.40 4.10 -10 8.20 6.00
Net Income / (Loss) Attributable to Noncontrolling Interest
0.20 0.20 0.40 0.60 0.10 0.30 0.20 0.40 0.40 0.50 0.50
Basic Earnings per Share
$0.78 ($0.22) $0.29 ($0.20) ($0.13) ($0.18) $0.06 ($0.46) ($1.18) $0.11 $0.30
Weighted Average Basic Shares Outstanding
34.02M 34.34M 33.20M 31.85M 31.85M 32.20M 32.20M 32.21M 51.48M 51.89M 51.90M
Diluted Earnings per Share
$0.77 ($0.22) $0.29 ($0.20) ($0.13) ($0.18) $0.06 ($0.46) ($1.18) $0.10 $0.30
Weighted Average Diluted Shares Outstanding
34.02M 34.34M 33.20M 31.85M 31.85M 32.20M 32.20M 32.21M 51.48M 51.89M 51.90M
Weighted Average Basic & Diluted Shares Outstanding
34.02M 34.34M 33.20M 31.85M 31.85M 32.20M 32.20M 32.21M 51.48M 51.89M 51.90M
Cash Dividends to Common per Share
$0.19 $0.19 $0.19 $0.19 $0.19 $0.19 $0.19 $0.19 $0.19 $0.19 $0.19

Annual Cash Flow Statements for Ryerson

This table details how cash moves in and out of Ryerson's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
3.20 16 -8.60 -50 71 2.70 -10 -12 15 -26 -1.50
Net Cash From Operating Activities
259 25 -4.00 57 193 278 35 501 365 205 87
Net Cash From Continuing Operating Activities
259 25 -4.00 57 193 278 35 501 365 205 87
Net Income / (Loss) Continuing Operations
-1.80 19 18 106 83 -65 295 392 146 -7.30 -55
Consolidated Net Income / (Loss)
-1.80 19 18 106 83 -65 295 392 146 -7.30 -55
Depreciation Expense
44 43 47 53 58 54 56 59 63 78 80
Non-Cash Adjustments To Reconcile Net Income
26 24 0.10 78 -9.50 77 31 7.70 17 24 16
Changes in Operating Assets and Liabilities, net
191 -3.30 117 140 62 213 -347 43 139 111 46
Net Cash From Investing Activities
-18 -20 -70 -200 26 -26 94 -160 -262 -143 -54
Net Cash From Continuing Investing Activities
-18 -20 -70 -200 26 -26 94 -160 -262 -143 -54
Purchase of Property, Plant & Equipment
-22 -23 -25 -38 -46 -26 -59 -105 -122 -100 -52
Acquisitions
-8.80 - -49 -170 0.00 0.00 -15 -57 -138 -44 0.00
Purchase of Investments
- - - - - 0.00 0.00 -2.00 0.00 0.00 0.00
Sale of Property, Plant & Equipment
10 3.20 3.80 5.90 70 0.10 166 8.00 0.50 2.10 2.60
Other Investing Activities, net
2.70 - 0.20 2.00 1.80 0.00 1.90 -3.90 -2.90 -1.10 -4.70
Net Cash From Financing Activities
-232 11 66 93 -184 -250 -138 -350 -88 -87 -37
Net Cash From Continuing Financing Activities
-232 11 66 93 -184 -250 -138 -350 -88 -87 -37
Repayment of Debt
-226 - -0.20 -52 -191 -777 -168 -333 -640 -593 -782
Repurchase of Common Equity
- - - - 0.00 0.00 -1.80 -50 -114 -51 0.00
Payment of Dividends
- - 0.00 -0.20 0.00 -0.20 -6.40 -20 -25 -25 -24
Issuance of Debt
- 1,436 74 150 0.00 500 46 26 701 617 776
Other Financing Activities, net
-5.80 5.90 -8.40 -4.40 7.10 27 -7.70 27 -11 -34 -6.50
Effect of Exchange Rate Changes
-5.70 - - - - 0.90 -1.60 -3.00 0.20 -1.50 1.60
Cash Interest Paid
87 89 85 93 88 62 51 38 30 41 41
Cash Income Taxes Paid
3.20 1.80 1.70 2.10 -6.60 -5.70 70 177 6.20 10 5.70

Quarterly Cash Flow Statements for Ryerson

This table details how cash moves in and out of Ryerson's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents
17 -12 -14 7.60 -7.50 5.40 -2.50 -1.80 -2.60 -1.10 17
Net Cash From Operating Activities
90 -48 26 135 92 -41 24 -8.30 113 -179 21
Net Cash From Continuing Operating Activities
90 -48 26 135 92 -41 24 -8.30 113 -179 21
Net Income / (Loss) Continuing Operations
26 -7.40 10 -6.00 -4.20 -5.30 2.10 -14 -38 5.00 16
Consolidated Net Income / (Loss)
26 -7.40 10 -6.00 -4.20 -5.30 2.10 -14 -38 5.00 16
Depreciation Expense
20 17 18 20 23 19 19 20 21 23 32
Non-Cash Adjustments To Reconcile Net Income
13 6.30 2.50 4.00 11 1.60 5.40 1.80 7.40 2.20 11
Changes in Operating Assets and Liabilities, net
31 -64 -4.90 117 63 -57 -3.10 -16 122 -210 -37
Net Cash From Investing Activities
-115 -20 -23 -75 -24 -8.00 -13 -9.90 -23 -281 -12
Net Cash From Continuing Investing Activities
-115 -20 -23 -75 -24 -8.00 -13 -9.90 -23 -281 -12
Purchase of Property, Plant & Equipment
-25 -22 -23 -32 -24 -8.00 -9.90 -13 -21 -12 -16
Sale of Property, Plant & Equipment
0.40 1.40 0.10 0.40 0.20 0.10 0.20 2.30 - 1.10 4.40
Other Investing Activities, net
-2.70 0.00 - -0.10 -0.60 -0.10 -3.30 0.60 -1.90 0.10 0.40
Net Cash From Financing Activities
41 56 -17 -52 -75 54 -14 16 -93 459 6.50
Net Cash From Continuing Financing Activities
41 56 -17 -52 -75 54 -14 16 -93 459 6.50
Repayment of Debt
-2.40 -2.00 -3.80 -1.50 -1.30 -132 -1.40 -554 -225 -200 -255
Repurchase of Common Equity
-6.30 -1.00 -14 -36 - 0.00 - - - -1.60 -0.80
Payment of Dividends
-6.30 -6.40 -6.40 -6.00 -6.00 -6.00 -6.00 -6.00 -6.10 -9.70 -9.70
Issuance of Debt
71 61 29 -3.60 -55 160 15 543 189 643 300
Other Financing Activities, net
-15 4.60 -22 -4.90 -12 32 -21 33 -50 27 -28
Effect of Exchange Rate Changes
1.20 -0.40 -0.20 0.40 -1.30 0.20 0.70 - 0.70 0.00 0.20
Cash Interest Paid
9.20 11 9.60 12 8.40 9.30 9.80 11 11 7.50 13
Cash Income Taxes Paid
-0.40 6.40 1.10 1.00 1.80 1.90 1.00 1.90 0.90 1.80 1.00

Annual Balance Sheets for Ryerson

This table presents Ryerson's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
1,545 1,559 1,712 2,086 2,022 1,802 2,366 2,334 2,570 2,440 2,405
Total Current Assets
959 998 1,104 1,413 1,280 1,103 1,593 1,442 1,383 1,208 1,223
Cash & Equivalents
63 81 77 23 11 61 51 39 54 28 27
Restricted Cash
1.20 1.00 1.10 1.10 49 1.10 1.20 1.30 1.10 1.60 0.90
Accounts Receivable
306 326 376 521 425 379 631 514 468 426 461
Inventories, net
556 563 617 806 743 605 832 799 783 685 648
Prepaid Expenses
33 27 33 62 52 58 78 88 78 68 86
Plant, Property, & Equipment, net
400 388 423 489 440 422 388 458 590 637 610
Plant, Property & Equipment, gross
- - - - - - - - - - 1,180
Accumulated Depreciation
- - - - - - - - - - 570
Total Noncurrent Assets
186 173 185 184 302 277 384 434 597 595 572
Goodwill
103 103 115 120 120 120 124 129 158 162 162
Intangible Assets
46 41 47 58 51 43 42 51 74 68 58
Other Noncurrent Operating Assets
5.00 4.30 5.00 5.80 131 113 218 254 365 365 352
Total Liabilities & Shareholders' Equity
1,545 1,559 1,712 2,086 2,022 1,802 2,366 2,334 2,570 2,440 2,405
Total Liabilities
1,686 1,608 1,719 2,010 1,843 1,657 1,821 1,441 1,655 1,615 1,641
Total Current Liabilities
316 332 403 569 492 528 751 619 634 580 668
Short-Term Debt
22 19 21 27 49 14 29 5.80 8.20 0.70 1.90
Accounts Payable
206 230 275 390 312 365 481 438 463 441 516
Accrued Expenses
36 28 48 134 94 121 210 145 128 103 72
Current Employee Benefit Liabilities
35 45 48 7.90 7.00 6.60 6.10 4.80 4.00 3.70 3.70
Other Current Liabilities
- - - 0.00 21 21 25 25 31 32 75
Total Noncurrent Liabilities
1,370 1,276 1,317 1,441 1,351 1,129 1,070 822 1,021 1,035 973
Long-Term Debt
1,002 944 1,024 1,126 933 726 611 361 428 467 461
Noncurrent Deferred & Payable Income Tax Liabilities
- - - 13 65 58 94 114 136 129 110
Noncurrent Employee Benefit Liabilities
328 299 244 258 218 232 163 118 107 91 70
Other Noncurrent Operating Liabilities
41 33 49 44 136 20 202 229 351 348 331
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-141 -49 -7.40 76 179 145 545 893 915 825 764
Total Preferred & Common Equity
-142 -51 -10 73 173 139 537 885 906 815 753
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
-142 -51 -10 73 173 139 537 885 906 815 753
Common Stock
303 376 378 381 382 384 389 398 412 424 433
Retained Earnings
-131 -112 -95 14 100 34 322 693 813 780 699
Treasury Stock
-6.60 -6.60 -6.60 -6.60 -6.60 -6.60 -8.40 -61 -179 -234 -237
Accumulated Other Comprehensive Income / (Loss)
-307 -308 -286 -316 -302 -272 -165 -144 -140 -154 -142
Noncontrolling Interest
0.70 1.50 2.60 2.70 6.00 6.30 7.40 7.90 8.60 9.20 11

Quarterly Balance Sheets for Ryerson

This table presents Ryerson's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets
2,402 2,522 2,434 2,720 2,591 2,533 2,524 2,538 2,490 3,724 3,842
Total Current Assets
1,457 1,448 1,359 1,525 1,389 1,301 1,298 1,325 1,304 2,111 2,267
Cash & Equivalents
44 30 37 42 28 35 34 31 30 25 42
Restricted Cash
1.30 1.10 1.10 1.10 1.20 1.80 1.10 1.40 0.60 1.60 1.40
Accounts Receivable
615 581 545 549 529 500 528 533 521 847 927
Inventories, net
711 754 699 841 744 681 657 676 679 1,131 1,194
Prepaid Expenses
85 83 76 93 87 84 78 84 74 107 102
Plant, Property, & Equipment, net
486 532 544 595 603 635 628 619 607 879 922
Plant, Property & Equipment, gross
938 994 1,011 1,081 1,099 1,135 1,159 1,164 1,157 1,461 1,529
Accumulated Depreciation
452 462 467 487 495 500 531 545 550 583 607
Total Noncurrent Assets
459 542 532 600 599 597 598 594 579 734 653
Goodwill
135 136 136 161 161 160 162 162 162 162 164
Intangible Assets
64 63 60 71 69 71 66 64 61 157 82
Other Noncurrent Operating Assets
259 343 335 368 369 366 370 369 357 415 407
Total Liabilities & Shareholders' Equity
2,402 2,522 2,434 2,720 2,591 2,533 2,524 2,538 2,490 3,724 3,842
Total Liabilities
1,521 1,655 1,543 1,823 1,705 1,691 1,710 1,717 1,693 2,431 2,543
Total Current Liabilities
665 712 634 729 583 585 647 651 657 954 1,028
Short-Term Debt
4.00 3.50 5.90 3.70 1.40 1.80 0.30 1.40 1.50 2.60 2.60
Accounts Payable
522 557 478 580 439 444 508 506 515 749 788
Accrued Expenses
71 73 72 111 69 104 66 67 104 99 115
Current Employee Benefit Liabilities
42 49 49 4.00 43 4.00 3.70 43 3.80 63 80
Other Current Liabilities
26 29 29 30 30 32 69 33 33 42 42
Total Noncurrent Liabilities
855 943 910 1,094 1,122 1,106 1,063 1,066 1,036 1,477 1,515
Long-Term Debt
391 393 360 494 524 520 497 509 498 905 953
Noncurrent Deferred & Payable Income Tax Liabilities
119 125 131 141 139 136 130 128 123 116 122
Noncurrent Employee Benefit Liabilities
112 112 111 106 103 97 83 81 78 92 89
Other Noncurrent Operating Liabilities
233 314 308 354 356 353 353 348 337 363 352
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
881 866 891 897 886 842 813 821 797 1,293 1,299
Total Preferred & Common Equity
873 858 883 889 878 833 804 812 787 1,282 1,288
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
873 858 883 889 878 833 804 812 787 1,282 1,288
Common Stock
401 404 408 416 420 423 428 431 430 974 977
Retained Earnings
734 765 794 799 803 790 768 764 743 694 699
Treasury Stock
-118 -169 -173 -184 -198 -234 -237 -237 -237 -240 -241
Accumulated Other Comprehensive Income / (Loss)
-144 -142 -146 -142 -146 -146 -155 -146 -149 -145 -147
Noncontrolling Interest
8.00 8.10 8.30 8.70 8.50 9.10 9.40 9.70 10 11 10

Annual Metrics And Ratios for Ryerson

This table displays calculated financial ratios and metrics derived from Ryerson's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-12.56% -9.71% 17.66% 31.02% 2.11% -22.99% 63.71% 11.42% -19.21% -9.98% -0.60%
EBITDA Growth
12.53% 11.70% -2.33% 28.55% 34.07% -84.93% 1,393.03% 6.03% -54.29% -61.09% -58.13%
EBIT Growth
21.99% 18.13% -7.16% 35.65% 42.64% -106.57% 4,072.99% 6.08% -60.44% -84.41% -190.73%
NOPAT Growth
-270.11% 185.94% 23.25% 16.47% 19.24% -70.12% 815.32% 4.68% -60.21% -87.21% -197.78%
Net Income Growth
93.13% 1,150.00% -4.76% 491.11% -22.27% -178.96% 552.37% 32.53% -62.61% -104.99% -654.79%
EPS Growth
98.02% 2,800.00% -14.81% 510.87% -22.78% -179.72% 536.99% 35.05% -59.84% -106.34% -576.92%
Operating Cash Flow Growth
453.21% -90.42% -116.13% 1,535.00% 236.41% 43.92% -87.41% 1,332.00% -27.15% -43.88% -57.54%
Free Cash Flow Firm Growth
55.66% -48.01% -123.16% -537.27% 316.90% -6.45% -17.37% 74.37% -72.11% -42.83% -23.45%
Invested Capital Growth
-23.54% 1.01% 15.14% 25.26% -8.63% -17.51% 23.58% 7.78% 6.24% -2.55% -5.05%
Revenue Q/Q Growth
-5.93% 0.47% 3.97% 8.61% -4.22% -3.03% 13.63% -3.74% -3.33% -2.23% 2.18%
EBITDA Q/Q Growth
-22.67% 14.44% 8.40% -22.96% 59.76% -76.63% 121.48% -28.94% 35.24% -23.67% -48.87%
EBIT Q/Q Growth
-28.84% 19.71% 9.90% -29.79% 94.77% -111.67% 150.71% -31.07% 46.22% -51.43% -388.39%
NOPAT Q/Q Growth
-212.96% 2.00% 5.78% 5.22% 17.50% -44.88% 37.88% -23.44% 42.48% -58.90% -417.53%
Net Income Q/Q Growth
-107.44% 215.00% 93.55% 0.38% 45.09% -191.52% 71.35% -24.97% 51.55% -131.88% -152.75%
EPS Q/Q Growth
-103.03% 200.00% 142.11% 0.72% 45.64% -188.33% 71.82% -24.09% 45.91% -140.63% -147.89%
Operating Cash Flow Q/Q Growth
68.12% -42.86% 91.23% 125.98% -23.31% -22.66% 138.63% 17.54% -20.04% 1.04% 30.83%
Free Cash Flow Firm Q/Q Growth
0.00% -43.32% -187.34% 54.46% -15.80% -42.40% 213.87% 11.95% -56.21% 199.83% -37.47%
Invested Capital Q/Q Growth
-9.85% -3.24% 1.84% -8.81% -4.05% 11.28% 6.76% -7.43% 6.33% -4.87% -5.35%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
17.92% 19.95% 17.31% 17.20% 18.39% 17.92% 20.21% 20.72% 20.00% 18.14% 17.11%
EBITDA Margin
4.48% 5.54% 4.60% 4.51% 5.93% 1.16% 10.58% 10.06% 5.69% 2.46% 1.04%
Operating Margin
3.43% 4.27% 3.00% 3.16% 4.68% 1.86% 9.61% 9.15% 4.46% 0.69% -0.67%
EBIT Margin
3.10% 4.06% 3.20% 3.31% 4.63% -0.40% 9.59% 9.13% 4.47% 0.77% -0.71%
Profit (Net Income) Margin
-0.06% 0.66% 0.54% 2.41% 1.84% -1.88% 5.21% 6.19% 2.87% -0.16% -1.21%
Tax Burden Percent
-94.74% 72.41% 107.78% 91.17% 71.79% 72.48% 75.92% 74.87% 75.58% 98.65% 77.39%
Interest Burden Percent
1.93% 22.50% 15.51% 79.88% 55.28% 657.66% 71.49% 90.56% 84.81% -20.79% 220.43%
Effective Tax Rate
194.74% 27.59% -7.78% 8.83% 28.21% 0.00% 24.08% 25.13% 24.42% 0.00% 0.00%
Return on Invested Capital (ROIC)
-10.69% 10.55% 12.03% 11.62% 13.02% 4.46% 40.44% 36.86% 13.71% 1.72% -1.75%
ROIC Less NNEP Spread (ROIC-NNEP)
-1.46% 3.10% 2.29% 9.68% 6.39% -8.52% 22.98% 27.71% 6.36% -5.44% -9.43%
Return on Net Nonoperating Assets (RNNOA)
12.05% -30.43% -75.52% 299.04% 51.97% -44.81% 45.22% 17.61% 2.49% -2.56% -5.19%
Return on Equity (ROE)
1.36% -19.88% -63.49% 310.66% 64.99% -40.35% 85.66% 54.47% 16.20% -0.84% -6.94%
Cash Return on Invested Capital (CROIC)
15.99% 9.55% -2.05% -10.81% 22.03% 23.66% 19.35% 29.37% 7.66% 4.30% 3.42%
Operating Return on Assets (OROA)
5.75% 7.47% 6.59% 7.69% 10.15% -0.72% 26.12% 24.57% 9.32% 1.42% -1.33%
Return on Assets (ROA)
-0.11% 1.22% 1.10% 5.60% 4.03% -3.42% 14.18% 16.66% 5.97% -0.29% -2.27%
Return on Common Equity (ROCE)
1.38% -20.12% -68.08% 286.62% 62.77% -38.81% 83.96% 53.89% 16.05% -0.83% -6.85%
Return on Equity Simple (ROE_SIMPLE)
1.27% -37.20% -180.00% 145.36% 47.91% -47.05% 54.99% 44.23% 16.16% -0.90% 0.00%
Net Operating Profit after Tax (NOPAT)
-103 88 109 127 151 45 414 433 172 22 -22
NOPAT Margin
-3.25% 3.09% 3.24% 2.88% 3.36% 1.30% 7.29% 6.85% 3.37% 0.48% -0.47%
Net Nonoperating Expense Percent (NNEP)
-9.24% 7.45% 9.74% 1.94% 6.63% 12.99% 17.46% 9.15% 7.35% 7.17% 7.68%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 34.39% 12.76% 1.71% -1.76%
Cost of Revenue to Revenue
82.08% 80.05% 82.69% 82.80% 81.61% 82.08% 79.79% 79.28% 80.00% 81.86% 82.89%
SG&A Expenses to Revenue
14.23% 15.65% 14.31% 13.94% 14.15% 15.99% 12.53% 11.63% 15.53% 17.42% 17.71%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
14.50% 15.68% 14.31% 14.04% 13.71% 16.05% 10.60% 11.57% 15.53% 17.45% 17.78%
Earnings before Interest and Taxes (EBIT)
98 116 108 146 208 -14 544 577 228 36 -32
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
142 159 155 199 267 40 600 636 291 113 47
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 3.05 2.44 3.52 1.76 1.20 1.27 0.72 1.08
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 247.26 0.00 2.55 1.50 1.70 1.01 1.52
Price to Revenue (P/Rev)
0.04 0.16 0.11 0.05 0.09 0.14 0.17 0.17 0.22 0.13 0.18
Price to Earnings (P/E)
0.00 24.93 21.28 2.11 5.10 0.00 3.22 2.71 7.87 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.67% 1.87% 2.14% 4.05% 2.98%
Earnings Yield
0.00% 4.01% 4.70% 47.48% 19.60% 0.00% 31.09% 36.86% 12.70% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
1.32 1.60 1.38 1.12 1.21 1.38 1.36 1.14 1.19 0.82 1.05
Enterprise Value to Revenue (EV/Rev)
0.35 0.47 0.40 0.31 0.30 0.37 0.27 0.22 0.30 0.23 0.27
Enterprise Value to EBITDA (EV/EBITDA)
7.76 8.51 8.62 6.81 5.05 31.49 2.57 2.19 5.28 9.16 26.50
Enterprise Value to EBIT (EV/EBIT)
11.21 11.63 12.38 9.27 6.47 0.00 2.83 2.42 6.73 29.12 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 15.26 12.24 10.68 8.91 27.99 3.72 3.22 8.92 47.02 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
4.25 54.41 0.00 23.61 6.98 4.55 44.03 2.78 4.21 5.06 14.44
Enterprise Value to Free Cash Flow (EV/FCFF)
7.15 16.86 0.00 0.00 5.26 5.28 7.78 4.04 15.96 18.83 29.81
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
-7.27 -19.54 -141.31 15.20 5.50 5.74 1.17 0.41 0.48 0.57 0.61
Long-Term Debt to Equity
-7.11 -19.15 -138.43 14.84 5.22 5.65 1.12 0.40 0.47 0.57 0.60
Financial Leverage
-8.28 -9.82 -32.96 30.89 8.13 5.26 1.97 0.64 0.39 0.47 0.55
Leverage Ratio
-12.93 -16.33 -57.68 55.45 16.14 11.81 6.04 3.27 2.71 2.88 3.05
Compound Leverage Factor
-0.25 -3.67 -8.94 44.29 8.92 77.68 4.32 2.96 2.30 -0.60 6.72
Debt to Total Capital
115.95% 105.39% 100.71% 93.83% 84.61% 85.17% 54.00% 29.13% 32.31% 36.18% 37.75%
Short-Term Debt to Total Capital
2.49% 2.10% 2.05% 2.22% 4.24% 1.41% 2.43% 0.46% 0.61% 0.05% 0.15%
Long-Term Debt to Total Capital
113.46% 103.29% 98.66% 91.60% 80.37% 83.75% 51.57% 28.67% 31.70% 36.13% 37.60%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.09% 0.16% 0.25% 0.22% 0.52% 0.64% 0.63% 0.63% 0.64% 0.71% 0.86%
Common Equity to Total Capital
-16.04% -5.56% -0.96% 5.96% 14.87% 14.19% 45.38% 70.25% 67.05% 63.11% 61.39%
Debt to EBITDA
7.21 6.08 6.76 5.80 3.68 20.72 1.07 0.58 1.50 4.13 9.77
Net Debt to EBITDA
6.76 5.56 6.25 5.67 3.46 19.17 0.98 0.51 1.31 3.87 9.18
Long-Term Debt to EBITDA
7.06 5.96 6.62 5.66 3.50 20.38 1.02 0.57 1.47 4.12 9.73
Debt to NOPAT
-9.95 10.90 9.60 9.09 6.49 18.42 1.54 0.85 2.53 21.20 -21.48
Net Debt to NOPAT
-9.32 9.97 8.88 8.90 6.09 17.04 1.42 0.75 2.21 19.87 -20.19
Long-Term Debt to NOPAT
-9.73 10.68 9.40 8.87 6.16 18.12 1.48 0.83 2.48 21.17 -21.39
Altman Z-Score
2.69 2.67 2.71 2.91 3.24 2.49 4.09 4.81 3.49 2.91 2.84
Noncontrolling Interest Sharing Ratio
-1.29% -1.21% -7.23% 7.74% 3.42% 3.80% 1.99% 1.06% 0.91% 1.02% 1.24%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
3.04 3.00 2.74 2.48 2.60 2.09 2.12 2.33 2.18 2.08 1.83
Quick Ratio
1.17 1.22 1.13 0.96 0.89 0.83 0.91 0.89 0.82 0.78 0.73
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
154 80 -19 -118 256 240 198 345 96 55 42
Operating Cash Flow to CapEx
2,175.63% 125.25% -18.78% 176.62% 0.00% 1,072.97% 0.00% 516.17% 300.74% 210.15% 177.91%
Free Cash Flow to Firm to Interest Expense
1.60 0.89 -0.20 -1.19 2.75 3.14 1.28 6.34 2.78 1.28 1.08
Operating Cash Flow to Interest Expense
2.69 0.28 -0.04 0.58 2.07 3.64 0.23 9.20 10.52 4.77 2.24
Operating Cash Flow Less CapEx to Interest Expense
2.56 0.06 -0.28 0.25 2.34 3.30 0.91 7.41 7.02 2.50 0.98
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.85 1.84 2.06 2.32 2.19 1.81 2.72 2.69 2.08 1.84 1.89
Accounts Receivable Turnover
8.97 9.05 9.58 9.83 9.52 8.62 11.24 11.04 10.40 10.30 10.31
Inventory Turnover
4.02 4.09 4.72 5.13 4.74 4.22 6.30 6.15 5.17 5.13 5.69
Fixed Asset Turnover
7.65 7.25 8.30 9.67 9.69 8.05 14.01 14.94 9.75 7.50 7.33
Accounts Payable Turnover
12.17 10.48 11.01 10.98 10.47 8.41 10.70 10.90 9.06 8.33 7.92
Days Sales Outstanding (DSO)
40.71 40.31 38.09 37.15 38.36 42.33 32.47 33.05 35.08 35.45 35.39
Days Inventory Outstanding (DIO)
90.90 89.23 77.40 71.13 76.96 86.42 57.90 59.36 70.60 71.12 64.20
Days Payable Outstanding (DPO)
29.98 34.82 33.15 33.26 34.86 43.39 34.11 33.48 40.27 43.83 46.08
Cash Conversion Cycle (CCC)
101.62 94.73 82.34 75.02 80.46 85.35 56.26 58.93 65.41 62.74 53.50
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
834 842 970 1,215 1,110 916 1,132 1,220 1,296 1,263 1,199
Invested Capital Turnover
3.29 3.41 3.71 4.04 3.87 3.42 5.54 5.38 4.06 3.60 3.71
Increase / (Decrease) in Invested Capital
-257 8.40 128 245 -105 -194 216 88 76 -33 -64
Enterprise Value (EV)
1,101 1,349 1,334 1,355 1,348 1,266 1,541 1,395 1,537 1,037 1,256
Market Capitalization
141 466 364 223 420 489 947 1,061 1,147 589 810
Book Value per Share
($4.41) ($1.37) ($0.27) $1.95 $4.57 $3.64 $13.99 $23.91 $26.51 $25.60 $23.38
Tangible Book Value per Share
($9.07) ($5.25) ($4.63) ($2.81) $0.05 ($0.65) $9.66 $19.05 $19.74 $18.38 $16.56
Total Capital
883 914 1,038 1,229 1,160 978 1,184 1,260 1,351 1,292 1,227
Total Debt
1,024 964 1,046 1,153 982 833 639 367 437 467 463
Total Long-Term Debt
1,002 944 1,024 1,126 933 819 611 361 428 467 461
Net Debt
959 882 967 1,129 922 771 587 327 381 438 435
Capital Expenditures (CapEx)
12 20 21 33 -25 26 -107 97 121 98 49
Debt-free, Cash-free Net Working Capital (DFCFNWC)
601 603 644 847 778 527 818 788 702 599 529
Debt-free Net Working Capital (DFNWC)
665 685 723 871 837 590 871 828 758 628 557
Net Working Capital (NWC)
643 665 701 844 788 576 842 822 750 628 555
Net Nonoperating Expense (NNE)
-101 70 91 21 69 111 119 42 26 29 34
Net Nonoperating Obligations (NNO)
975 892 977 1,139 931 771 587 327 381 438 435
Total Depreciation and Amortization (D&A)
44 43 47 53 58 54 56 59 63 78 80
Debt-free, Cash-free Net Working Capital to Revenue
18.96% 21.08% 19.14% 19.22% 17.27% 15.21% 14.42% 12.46% 13.75% 13.02% 11.57%
Debt-free Net Working Capital to Revenue
21.00% 23.94% 21.47% 19.77% 18.60% 17.01% 15.34% 13.10% 14.83% 13.66% 12.18%
Net Working Capital to Revenue
20.30% 23.27% 20.84% 19.15% 17.51% 16.61% 14.84% 13.01% 14.67% 13.65% 12.13%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.02) $0.55 $0.46 $2.84 $2.19 ($1.73) $7.67 $10.41 $4.17 ($0.26) ($1.76)
Adjusted Weighted Average Basic Shares Outstanding
32.10M 37.13M 37.21M 37.45M 37.78M 38.12M 38.39M 36.99M 34.02M 31.85M 51.48M
Adjusted Diluted Earnings per Share
($0.02) $0.54 $0.46 $2.81 $2.17 ($1.73) $7.56 $10.21 $4.10 ($0.26) ($1.76)
Adjusted Weighted Average Diluted Shares Outstanding
32.10M 37.13M 37.21M 37.45M 37.78M 38.12M 38.39M 36.99M 34.02M 31.85M 51.48M
Adjusted Basic & Diluted Earnings per Share
($0.02) $0.00 $0.00 $0.00 $2.19 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
32.10M 37.13M 37.21M 37.45M 37.78M 38.12M 38.39M 36.99M 34.02M 31.85M 51.48M
Normalized Net Operating Profit after Tax (NOPAT)
82 89 71 131 137 47 331 430 172 23 -19
Normalized NOPAT Margin
2.58% 3.12% 2.10% 2.97% 3.05% 1.35% 5.83% 6.81% 3.37% 0.50% -0.42%
Pre Tax Income Margin
0.06% 0.91% 0.50% 2.65% 2.56% -2.60% 6.86% 8.27% 3.79% -0.16% -1.56%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
1.02 1.29 1.18 1.47 2.24 -0.18 3.51 10.59 6.58 0.83 -0.83
NOPAT to Interest Expense
-1.07 0.98 1.20 1.28 1.62 0.59 2.67 7.95 4.97 0.51 -0.55
EBIT Less CapEx to Interest Expense
0.90 1.07 0.95 1.15 2.50 -0.52 4.20 8.81 3.08 -1.44 -2.09
NOPAT Less CapEx to Interest Expense
-1.19 0.76 0.96 0.95 1.89 0.25 3.36 6.17 1.47 -1.75 -1.81
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.19% 0.00% -0.31% 2.17% 5.08% 16.94% -339.73% -43.74%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.19% 0.00% -0.31% 2.78% 17.85% 94.74% -1,038.36% -43.74%

Quarterly Metrics And Ratios for Ryerson

This table displays calculated financial ratios and metrics derived from Ryerson's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding
- - - - - 31,850,903.00 32,196,086.00 32,198,906.00 - 51,482,714.00 51,888,724.00
DEI Adjusted Shares Outstanding
- - - - - 31,850,903.00 32,196,086.00 32,198,906.00 - 51,482,714.00 51,888,724.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - -0.18 0.06 -0.46 - 0.09 0.30
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-13.65% -11.87% -8.78% -9.63% -9.44% -8.35% -4.59% 3.10% 9.67% 37.93% 71.57%
EBITDA Growth
633.72% -78.47% -41.72% -65.40% -55.63% 21.11% -46.24% -18.70% -161.79% 121.56% 196.94%
EBIT Growth
644.30% -99.14% -57.59% -91.13% -87.67% 333.33% -85.77% -103.92% -820.75% 857.69% 937.14%
NOPAT Growth
276.02% -98.95% -59.97% -91.00% -94.61% 187.50% -77.01% -118.87% -1,557.69% 445.83% 516.21%
Net Income Growth
209.24% -115.58% -72.61% -117.00% -116.15% 28.38% -79.61% -140.00% -792.86% 194.34% 661.90%
EPS Growth
248.08% -117.32% -72.64% -120.00% -116.88% 18.18% -79.31% -130.00% -807.69% 155.56% 400.00%
Operating Cash Flow Growth
-50.39% -159.45% -77.54% 69.74% 2.33% 13.81% -8.11% -106.17% 22.23% -334.95% -44.85%
Free Cash Flow Firm Growth
60.50% -460.20% -186.66% -174.99% 182.24% 164.43% 165.49% 157.00% 6.75% -1,251.55% -1,113.59%
Invested Capital Growth
6.24% 9.78% 12.28% 8.93% -2.55% -5.59% -6.03% -4.57% -5.05% 70.37% 70.16%
Revenue Q/Q Growth
-10.77% 11.40% -1.11% -8.07% -10.58% 12.74% 2.96% -0.67% -4.88% 41.79% 28.07%
EBITDA Q/Q Growth
-11.25% -71.47% 136.67% -42.25% 13.82% -22.14% 5.05% -12.66% -186.50% 379.19% 40.79%
EBIT Q/Q Growth
-25.22% -98.60% 4,000.00% -79.27% 3.92% -50.94% 34.62% -105.71% -19,000.00% 165.18% 45.78%
NOPAT Q/Q Growth
-18.12% -98.34% 3,053.06% -78.99% -50.94% -11.54% 152.17% -117.24% -3,690.00% 133.12% 184.69%
Net Income Q/Q Growth
-26.35% -128.46% 239.19% -158.25% 30.00% -26.19% 139.62% -785.71% -160.42% 113.33% 220.00%
EPS Q/Q Growth
-23.00% -128.57% 231.82% -168.97% 35.00% -38.46% 133.33% -866.67% -156.52% 108.47% 200.00%
Operating Cash Flow Q/Q Growth
13.62% -153.05% 154.18% 419.69% -31.50% -144.69% 157.77% -134.87% 1,457.83% -259.01% 111.94%
Free Cash Flow Firm Q/Q Growth
-130.21% -183.05% -11.43% 21.31% 133.13% 121.74% 13.28% -31.51% -37.95% -2,492.02% 0.30%
Invested Capital Q/Q Growth
6.33% 4.31% 2.30% -4.00% -4.87% 1.05% 1.83% -2.50% -5.35% 81.32% 1.70%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
22.22% 17.56% 18.24% 17.93% 18.97% 18.00% 17.91% 17.18% 15.29% 18.44% 17.71%
EBITDA Margin
5.67% 1.45% 3.48% 2.18% 2.78% 1.92% 1.96% 1.72% -1.57% 3.08% 3.39%
Operating Margin
3.91% 0.06% 1.86% 0.47% 0.26% 0.20% 0.50% -0.09% -3.43% 1.48% 1.71%
EBIT Margin
3.87% 0.05% 2.01% 0.45% 0.53% 0.23% 0.30% -0.02% -3.46% 1.59% 1.81%
Profit (Net Income) Margin
2.34% -0.60% 0.84% -0.53% -0.42% -0.47% 0.18% -1.24% -3.39% 0.32% 0.80%
Tax Burden Percent
77.61% 77.89% 77.44% 93.75% 87.50% 76.81% -33.33% 139.81% 78.62% 37.88% 72.73%
Interest Burden Percent
77.91% -1,583.33% 54.07% -125.49% -90.57% -265.38% -180.00% 5,150.00% 124.87% 53.01% 60.61%
Effective Tax Rate
22.39% 0.00% 22.56% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 62.12% 27.27%
Return on Invested Capital (ROIC)
12.33% 0.17% 5.32% 1.22% 0.65% 0.49% 1.15% -0.21% -8.92% 1.63% 4.15%
ROIC Less NNEP Spread (ROIC-NNEP)
10.14% -1.81% 3.61% -1.17% -0.82% -1.02% 0.75% -3.08% -11.43% 1.06% 2.85%
Return on Net Nonoperating Assets (RNNOA)
3.97% -0.82% 1.77% -0.55% -0.39% -0.55% 0.43% -1.79% -6.29% 0.68% 1.87%
Return on Equity (ROE)
16.30% -0.64% 7.09% 0.67% 0.26% -0.06% 1.58% -2.00% -15.21% 2.31% 6.02%
Cash Return on Invested Capital (CROIC)
7.66% -0.09% -4.48% -4.33% 4.30% 7.51% 7.06% 5.20% 3.42% -52.46% -51.19%
Operating Return on Assets (OROA)
8.05% 0.09% 3.79% 0.86% 0.97% 0.39% 0.52% -0.03% -6.53% 2.55% 3.31%
Return on Assets (ROA)
4.87% -1.15% 1.59% -1.01% -0.77% -0.80% 0.31% -2.21% -6.41% 0.51% 1.46%
Return on Common Equity (ROCE)
16.15% -0.64% 7.02% 0.66% 0.26% -0.06% 1.56% -1.98% -15.02% 2.28% 5.96%
Return on Equity Simple (ROE_SIMPLE)
0.00% 10.30% 7.31% 2.75% 0.00% -0.65% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
34 0.56 18 3.71 1.82 1.61 4.06 -0.70 -27 8.79 25
NOPAT Margin
3.04% 0.05% 1.44% 0.33% 0.18% 0.14% 0.35% -0.06% -2.40% 0.56% 1.25%
Net Nonoperating Expense Percent (NNEP)
2.19% 1.98% 1.71% 2.39% 1.47% 1.51% 0.40% 2.87% 2.51% 0.56% 1.30%
Return On Investment Capital (ROIC_SIMPLE)
2.50% - - - 0.14% 0.12% 0.30% -0.05% -2.16% 0.40% 1.11%
Cost of Revenue to Revenue
77.78% 82.44% 81.76% 82.07% 81.03% 82.00% 82.09% 82.82% 84.71% 81.56% 82.29%
SG&A Expenses to Revenue
18.31% 17.50% 16.24% 17.48% 18.71% 17.80% 17.41% 17.26% 18.41% 16.93% 15.97%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
18.31% 17.50% 16.38% 17.46% 18.71% 17.80% 17.41% 17.26% 18.72% 16.96% 15.99%
Earnings before Interest and Taxes (EBIT)
43 0.60 25 5.10 5.30 2.60 3.50 -0.20 -38 25 36
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
63 18 43 25 28 22 23 20 -17 48 68
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.27 1.28 0.76 0.79 0.72 0.91 0.86 0.93 1.08 0.90 0.99
Price to Tangible Book Value (P/TBV)
1.70 1.73 1.03 1.10 1.01 1.27 1.18 1.30 1.52 1.20 1.23
Price to Revenue (P/Rev)
0.22 0.23 0.14 0.14 0.13 0.16 0.16 0.16 0.18 0.23 0.22
Price to Earnings (P/E)
7.87 12.50 10.61 30.75 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
2.14% 2.21% 3.81% 3.75% 4.05% 3.27% 3.48% 3.28% 2.98% 0.83% 1.52%
Earnings Yield
12.70% 8.00% 9.42% 3.25% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
1.19 1.18 0.85 0.87 0.82 0.94 0.91 0.96 1.05 0.94 0.99
Enterprise Value to Revenue (EV/Rev)
0.30 0.32 0.24 0.25 0.23 0.27 0.27 0.27 0.27 0.41 0.38
Enterprise Value to EBITDA (EV/EBITDA)
5.28 7.09 6.03 7.79 9.16 10.28 12.15 13.11 26.50 27.72 18.48
Enterprise Value to EBIT (EV/EBIT)
6.73 10.04 9.34 15.76 29.12 32.00 71.65 108.52 0.00 0.00 96.46
Enterprise Value to NOPAT (EV/NOPAT)
8.92 13.40 12.67 21.53 47.02 52.09 105.55 179.01 0.00 0.00 168.01
Enterprise Value to Operating Cash Flow (EV/OCF)
4.21 6.75 7.96 5.70 5.06 5.69 5.65 18.28 14.44 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
15.96 0.00 0.00 0.00 18.83 12.19 12.50 18.04 29.81 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.48 0.55 0.59 0.62 0.57 0.61 0.62 0.63 0.61 0.70 0.74
Long-Term Debt to Equity
0.47 0.55 0.59 0.62 0.57 0.61 0.62 0.62 0.60 0.70 0.73
Financial Leverage
0.39 0.45 0.49 0.47 0.47 0.54 0.57 0.58 0.55 0.64 0.66
Leverage Ratio
2.71 2.88 2.92 2.87 2.88 3.07 3.00 3.06 3.05 2.97 3.01
Compound Leverage Factor
2.11 -45.60 1.58 -3.60 -2.61 -8.14 -5.41 157.80 3.81 1.57 1.82
Debt to Total Capital
32.31% 35.66% 37.21% 38.27% 36.18% 37.94% 38.32% 38.52% 37.75% 41.25% 42.38%
Short-Term Debt to Total Capital
0.61% 0.27% 0.10% 0.13% 0.05% 0.02% 0.11% 0.12% 0.15% 0.12% 0.12%
Long-Term Debt to Total Capital
31.70% 35.40% 37.12% 38.14% 36.13% 37.92% 38.22% 38.41% 37.60% 41.13% 42.26%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.64% 0.62% 0.60% 0.67% 0.71% 0.72% 0.73% 0.78% 0.86% 0.48% 0.46%
Common Equity to Total Capital
67.05% 63.71% 62.18% 61.06% 63.11% 61.34% 60.95% 60.70% 61.39% 58.27% 57.16%
Debt to EBITDA
1.50 2.21 2.70 3.52 4.13 4.25 5.24 5.39 9.77 12.28 8.03
Net Debt to EBITDA
1.31 2.02 2.55 3.27 3.87 3.95 4.91 5.06 9.18 11.92 7.66
Long-Term Debt to EBITDA
1.47 2.19 2.69 3.51 4.12 4.25 5.23 5.37 9.73 12.25 8.01
Debt to NOPAT
2.53 4.17 5.67 9.73 21.20 21.53 45.55 73.59 -21.48 -130.98 72.97
Net Debt to NOPAT
2.21 3.81 5.36 9.04 19.87 20.03 42.68 69.12 -20.19 -127.13 69.66
Long-Term Debt to NOPAT
2.48 4.14 5.66 9.70 21.17 21.52 45.43 73.37 -21.39 -130.61 72.77
Altman Z-Score
3.25 2.95 2.94 2.87 2.87 2.78 2.74 2.79 2.83 2.28 2.49
Noncontrolling Interest Sharing Ratio
0.91% 0.94% 0.95% 1.00% 1.02% 1.06% 1.07% 1.17% 1.24% 0.94% 0.95%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.18 2.09 2.38 2.22 2.08 2.00 2.03 1.98 1.83 2.21 2.21
Quick Ratio
0.82 0.81 0.96 0.91 0.78 0.87 0.87 0.84 0.73 0.91 0.94
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-42 -120 -134 -105 35 77 87 60 37 -889 -886
Operating Cash Flow to CapEx
360.40% -234.31% 114.60% 431.41% 395.71% -521.52% 245.36% -79.05% 541.83% -1,614.41% 179.83%
Free Cash Flow to Firm to Interest Expense
-4.46 -11.87 -11.82 -9.14 3.45 8.13 8.92 5.93 3.91 -75.99 -61.99
Operating Cash Flow to Interest Expense
9.48 -4.73 2.29 11.70 9.13 -4.34 2.43 -0.82 11.86 -15.32 1.50
Operating Cash Flow Less CapEx to Interest Expense
6.85 -6.75 0.29 8.99 6.82 -5.17 1.44 -1.86 9.67 -16.27 0.66
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
2.08 1.93 1.89 1.89 1.84 1.71 1.73 1.78 1.89 1.60 1.83
Accounts Receivable Turnover
10.40 8.49 8.69 9.00 10.30 8.36 8.36 8.77 10.31 7.28 8.00
Inventory Turnover
5.17 5.11 5.19 5.53 5.13 4.90 5.12 5.40 5.69 4.63 5.16
Fixed Asset Turnover
9.75 9.14 8.50 7.98 7.50 7.35 7.26 7.20 7.33 6.64 7.58
Accounts Payable Turnover
9.06 7.20 7.80 8.27 8.33 6.75 7.68 7.66 7.92 6.58 7.46
Days Sales Outstanding (DSO)
35.08 42.98 41.98 40.53 35.45 43.68 43.65 41.63 35.39 50.15 45.63
Days Inventory Outstanding (DIO)
70.60 71.40 70.33 66.06 71.12 74.43 71.33 67.64 64.20 78.90 70.68
Days Payable Outstanding (DPO)
40.27 50.70 46.81 44.13 43.83 54.05 47.51 47.67 46.08 55.45 48.94
Cash Conversion Cycle (CCC)
65.41 63.68 65.50 62.47 62.74 64.06 67.48 61.61 53.50 73.60 67.37
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,296 1,352 1,383 1,327 1,263 1,276 1,299 1,267 1,199 2,174 2,211
Invested Capital Turnover
4.06 3.83 3.69 3.70 3.60 3.42 3.31 3.45 3.71 2.90 3.33
Increase / (Decrease) in Invested Capital
76 120 151 109 -33 -76 -83 -61 -64 898 912
Enterprise Value (EV)
1,537 1,598 1,174 1,155 1,037 1,203 1,182 1,215 1,256 2,049 2,199
Market Capitalization
1,147 1,135 670 661 589 731 694 736 810 1,157 1,277
Book Value per Share
$26.51 $25.88 $25.57 $25.09 $25.60 $25.24 $25.20 $24.45 $23.38 $24.91 $24.83
Tangible Book Value per Share
$19.74 $19.12 $18.88 $18.12 $18.38 $18.09 $18.22 $17.54 $16.56 $18.71 $20.09
Total Capital
1,351 1,395 1,412 1,364 1,292 1,311 1,331 1,297 1,227 2,201 2,254
Total Debt
437 497 525 522 467 497 510 500 463 908 955
Total Long-Term Debt
428 494 524 520 467 497 509 498 461 905 953
Net Debt
381 454 496 485 438 463 478 469 435 881 912
Capital Expenditures (CapEx)
25 20 23 31 23 7.90 9.70 11 21 11 12
Debt-free, Cash-free Net Working Capital (DFCFNWC)
702 757 778 681 599 616 643 618 529 1,133 1,198
Debt-free Net Working Capital (DFNWC)
758 800 808 718 628 651 675 648 557 1,160 1,242
Net Working Capital (NWC)
750 796 806 716 628 650 673 647 555 1,157 1,239
Net Nonoperating Expense (NNE)
7.76 7.96 7.36 9.71 6.02 6.91 1.96 14 11 3.79 9.02
Net Nonoperating Obligations (NNO)
381 454 496 485 438 463 478 469 435 881 912
Total Depreciation and Amortization (D&A)
20 17 18 20 23 19 19 20 21 23 32
Debt-free, Cash-free Net Working Capital to Revenue
13.75% 15.32% 16.13% 14.48% 13.02% 13.70% 14.48% 13.81% 11.57% 22.65% 20.52%
Debt-free Net Working Capital to Revenue
14.83% 16.19% 16.74% 15.27% 13.66% 14.47% 15.20% 14.49% 12.18% 23.18% 21.26%
Net Working Capital to Revenue
14.67% 16.11% 16.71% 15.23% 13.65% 14.47% 15.17% 14.45% 12.13% 23.13% 21.22%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.78 ($0.22) $0.29 ($0.20) ($0.13) ($0.18) $0.06 ($0.46) ($1.18) $0.11 $0.30
Adjusted Weighted Average Basic Shares Outstanding
34.02M 34.34M 33.20M 31.85M 31.85M 32.20M 32.20M 32.21M 51.48M 51.89M 51.90M
Adjusted Diluted Earnings per Share
$0.77 ($0.22) $0.29 ($0.20) ($0.13) ($0.18) $0.06 ($0.46) ($1.18) $0.10 $0.30
Adjusted Weighted Average Diluted Shares Outstanding
34.02M 34.34M 33.20M 31.85M 31.85M 32.20M 32.20M 32.21M 51.48M 51.89M 51.90M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
34.02M 34.34M 33.20M 31.85M 31.85M 32.20M 32.20M 32.21M 51.48M 51.89M 51.90M
Normalized Net Operating Profit after Tax (NOPAT)
34 0.56 19 3.57 1.82 1.61 4.06 -0.70 -27 17 25
Normalized NOPAT Margin
3.04% 0.05% 1.55% 0.32% 0.18% 0.14% 0.35% -0.06% -2.40% 1.05% 1.27%
Pre Tax Income Margin
3.01% -0.77% 1.09% -0.57% -0.48% -0.61% -0.54% -0.89% -4.32% 0.84% 1.10%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
4.53 0.06 2.18 0.44 0.52 0.27 0.36 -0.02 -4.02 2.13 2.54
NOPAT to Interest Expense
3.55 0.06 1.56 0.32 0.18 0.17 0.41 -0.07 -2.79 0.75 1.75
EBIT Less CapEx to Interest Expense
1.89 -1.96 0.18 -2.27 -1.78 -0.56 -0.63 -1.06 -6.21 1.18 1.71
NOPAT Less CapEx to Interest Expense
0.92 -1.96 -0.44 -2.39 -2.13 -0.66 -0.58 -1.11 -4.98 -0.20 0.92
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
16.94% 27.54% 39.56% 109.61% -339.73% -469.23% -179.10% -110.09% -43.74% -62.05% -101.94%
Augmented Payout Ratio
94.74% 94.97% 78.97% 359.83% -1,038.36% -1,430.77% -447.76% -110.09% -43.74% -65.63% -109.71%

Financials Breakdown Chart

Key Financial Trends

Ryerson Holding Corp. (NYSE: RYZ) showed a sharp operational rebound in Q1 2026, but cash flow remains under pressure and leverage is still a key factor for investors to watch. Revenue jumped year over year, margins improved meaningfully from late 2025, and the company returned to profitability. However, operating cash flow was deeply negative in the quarter, and Ryerson used significant debt financing while also completing an acquisition.

  • Revenue accelerated strongly in Q1 2026, rising to $1.57 billion from $1.16 billion in Q3 2025 and $1.11 billion in Q4 2025, showing a solid demand recovery.
  • Gross profit improved materially to $288.8 million in Q1 2026, up from $168.9 million in Q4 2025, indicating better pricing and/or volume leverage.
  • Operating income returned to positive territory at $23.2 million, compared with an operating loss of $37.9 million in Q4 2025.
  • Net income improved to $5.0 million, versus a loss of $37.5 million in the prior quarter, signaling a much better bottom line.
  • Net debt appears lower than a year ago on the balance sheet, with long-term debt of $905.1 million in Q1 2026 versus $1.03 billion in Q3 2025.
  • Liquidity improved in some working-capital areas, as current liabilities fell from $954.2 million in Q1 2026 to $656.9 million in Q3 2025, though this was offset by higher operating asset needs in the latest quarter.
  • Shares outstanding have been relatively stable recently, with diluted shares at about 51.9 million in Q1 2026 versus 51.5 million in Q4 2025.
  • The company continued paying a dividend of $0.1875 per share in Q1 2026, which may appeal to income-focused investors if cash generation stabilizes.
  • Inventory and receivables remain large, which is normal for a steel distribution business but means working capital can swing cash flow significantly.
  • Ryerson also completed acquisitions, including a $270 million acquisition in Q1 2026, suggesting management is still trying to grow through M&A.
  • Operating cash flow was deeply negative in Q1 2026 at $(179.2 million), mainly because working capital consumed $209.8 million.
  • Free cash generation remains volatile, with investing cash outflows of $(281.0 million) in Q1 2026 driven by acquisitions and capital spending.
  • Debt financing remains important: Ryerson issued $642.5 million of debt in Q1 2026 while repaying $199.5 million, showing continued reliance on the balance sheet.
  • Gross margin still looks cyclical; while improved, Q1 2026 revenue growth came with heavy operating capital use, which can quickly pressure earnings if demand softens.
  • The business has a history of earnings volatility, swinging from strong profits in 2023 to losses in parts of 2024 and 2025, underscoring its sensitivity to metals pricing and industrial demand.

Big picture: Ryerson’s latest quarter suggests the company is benefiting from a better operating environment, with stronger sales and a return to profitability. The main concern is cash flow: earnings improved, but cash was consumed by working capital and acquisitions. For retail investors, the key questions are whether the recent margin recovery can last and whether management can convert that improvement into sustained free cash flow while keeping leverage under control.

08/14/26 12:03 PM ETAI Generated. May Contain Errors.

Ryerson Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Ryerson's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Ryerson's net income appears to be on an upward trend, with a most recent value of -$55.10 million in 2025, rising from -$1.80 million in 2015. The previous period was -$7.30 million in 2024. Find out what analysts predict for Ryerson in the coming months.

Ryerson's total operating income in 2025 was -$30.80 million, based on the following breakdown:
  • Total Gross Profit: $782.20 million
  • Total Operating Expenses: $813 million

Over the last 10 years, Ryerson's total revenue changed from $3.17 billion in 2015 to $4.57 billion in 2025, a change of 44.3%.

Ryerson's total liabilities were at $1.64 billion at the end of 2025, a 1.6% increase from 2024, and a 2.7% decrease since 2015.

In the past 10 years, Ryerson's cash and equivalents has ranged from $11 million in 2019 to $80.70 million in 2016, and is currently $26.90 million as of their latest financial filing in 2025.

Over the last 10 years, Ryerson's book value per share changed from -4.41 in 2015 to 23.38 in 2025, a change of -630.0%.



Financial statements for NYSE:RYZ last updated on 7/29/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners